Share Email Print

Proceedings Paper

Endovenous laser ablation with TM-fiber laser
Author(s): Meral Filiz Somunyudan; Nermin Topaloglu; Mehmet Umit Ergenoglu; Murat Gulsoy
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Endovenous Laser Ablation (EVLA) has become a popular minimally invasive alternative to stripping in the treatment of saphenous vein reflux. Several wavelengths have been proposed; of which 810, 940 and 980- nm are the most commonly used. However, the most appropriate wavelength is still the subject of debate. Thermal shrinkage of collagenous tissue during EVLA plays a significant role in the early and late results of the treatment. The aim of this study is to compare the efficacy of 980 and 1940-nm laser wavelengths in the treatment of varicose veins. In this study, 980 and 1940-nm lasers at different power settings (8/10W for 980-nm, 2/3W for 1940-nm) were used to irradiate stripped human veins. The most prominent contraction and narrowing in outer and inner diameter were observed with the 1940-nm at 2W, following 980-nm at 8W, 1940-nm at 3W and finally 980-nm at 10W. The minimum carbonization was observed with the 1940-nm at 2W. As a conclusion, 1940-nm Tm-fiber laser which has a significant effect in the management of varicose veins due to more selective energy absorption in water and consequently in the vein is a promising method in the management of varicose veins.

Paper Details

Date Published: 22 February 2011
PDF: 6 pages
Proc. SPIE 7897, Optical Interactions with Tissue and Cells XXII, 789707 (22 February 2011); doi: 10.1117/12.875411
Show Author Affiliations
Meral Filiz Somunyudan, Bogazici Univ. (Turkey)
Nermin Topaloglu, Bogazici Univ. (Turkey)
Mehmet Umit Ergenoglu, Yeditepe Univ. Hospital (Turkey)
Murat Gulsoy, Bogazici Univ. (Turkey)

Published in SPIE Proceedings Vol. 7897:
Optical Interactions with Tissue and Cells XXII
E. Duco Jansen; Robert J. Thomas, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?